• LAST PRICE
    104.9200
  • TODAY'S CHANGE (%)
    Trending Up1.4200 (1.3720%)
  • Bid / Lots
    101.8800/ 5
  • Ask / Lots
    105.9700/ 1
  • Open / Previous Close
    105.2700 / 103.5000
  • Day Range
    Low 101.6800
    High 105.2800
  • 52 Week Range
    Low 41.4500
    High 113.5100
  • Volume
    308,522
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 103.5
TimeVolumeNUVL
09:32 ET7687104.42
09:34 ET2750105.14
09:36 ET2214104.86
09:38 ET400104.38
09:43 ET600104.94
09:45 ET2398104.545
09:48 ET100104.545
09:52 ET400104.96
09:54 ET1150105.225
09:56 ET2800104.425
10:01 ET100104.66
10:03 ET350104.84
10:06 ET100104.265
10:08 ET1900104.76
10:10 ET200104.73
10:14 ET1550104.04
10:17 ET250104.405
10:19 ET900104.85
10:24 ET2026104.4432
10:26 ET400103.9
10:28 ET125103.91
10:30 ET200103.7475
10:32 ET300103.69
10:33 ET100103.675
10:35 ET100103.64
10:39 ET400102.88
10:42 ET2100102.89
10:44 ET300103.06
10:46 ET100103.2
10:48 ET517103.01
10:50 ET100103.085
10:51 ET200102.74
10:53 ET300103.1
10:55 ET543103.125
10:57 ET300102.89
11:00 ET2017102.89
11:02 ET3240102.935
11:04 ET200102.72
11:06 ET300102.68
11:08 ET1000102.895
11:09 ET2200102.8
11:11 ET962102.62
11:13 ET200102.765
11:15 ET100102.38
11:18 ET18887102.535
11:20 ET400102.47
11:22 ET2000102.4
11:24 ET1300101.97
11:26 ET300101.83
11:27 ET100102.005
11:29 ET7477102.2
11:31 ET600101.95
11:33 ET3590102.72
11:36 ET920102.725
11:38 ET550102.769
11:42 ET332102.5121
11:44 ET800102.48
11:45 ET100102.42
11:47 ET600102.5
11:49 ET1300102.45
11:54 ET200102.56
11:56 ET2800102.35
11:58 ET200102.34
12:00 ET654102.415
12:02 ET1817102.655
12:05 ET1100102.605
12:12 ET400102.62
12:14 ET2101102.64
12:16 ET1350102.8275
12:18 ET200102.81
12:20 ET200102.88
12:21 ET1450102.79
12:23 ET300102.66
12:25 ET400102.51
12:27 ET100102.27
12:30 ET100102.61
12:32 ET100102.23
12:36 ET3146102.395
12:38 ET2476102.29
12:39 ET2700102.69
12:41 ET1280102.695
12:43 ET300102.75
12:45 ET438102.7898
12:50 ET200102.67
12:52 ET100102.64
12:54 ET200102.51
12:56 ET100102.5
12:57 ET100102.24
01:01 ET200102.39
01:03 ET100102.33
01:06 ET1000102.37
01:08 ET500102.31
01:10 ET400102.38
01:12 ET2050102.64
01:17 ET100102.985
01:19 ET200103.518
01:24 ET100103.62
01:28 ET200103.395
01:32 ET200103.05
01:35 ET600103.215
01:39 ET100103.14
01:42 ET666103.67
01:44 ET100103.725
01:46 ET300103.965
01:48 ET100104.229
01:50 ET200104.04
01:53 ET100103.875
01:57 ET100103.57
02:00 ET100103.795
02:02 ET3831104.28
02:04 ET400104.4
02:06 ET100104.22
02:08 ET100103.89
02:11 ET200103.745
02:15 ET400103.7
02:18 ET100103.895
02:20 ET500103.74
02:22 ET600103.75
02:24 ET300103.75
02:27 ET480103.99
02:29 ET100103.79
02:31 ET100103.98
02:33 ET200103.93
02:36 ET300104.05
02:38 ET500104.15
02:40 ET100104.27
02:42 ET100104.3
02:44 ET100104.22
02:47 ET100104.08
02:51 ET100104.16
02:54 ET600104.26
02:56 ET400104.11
03:00 ET800104.26
03:02 ET200104.26
03:03 ET100104.245
03:05 ET1250104.17
03:09 ET1100104.465
03:14 ET300104.29
03:18 ET264104.1
03:20 ET200104.205
03:21 ET300104.13
03:23 ET900104.47
03:25 ET466104.34
03:30 ET100104.365
03:32 ET200104.3825
03:34 ET279104.34
03:36 ET1100104.6968
03:38 ET400104.64
03:41 ET700104.66
03:43 ET1200104.72
03:45 ET300104.705
03:48 ET200104.47
03:50 ET1414104.28
03:52 ET3100104.916
03:54 ET1100104.82
03:56 ET3655105.13
03:57 ET2633105.06
03:59 ET54849104.92
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesNUVL
Nuvalent Inc
6.8B
-37.7x
---
United StatesCYTK
Cytokinetics Inc
6.6B
-10.6x
---
United StatesVKTX
Viking Therapeutics Inc
7.1B
-69.2x
---
United StatesRVMD
Revolution Medicines Inc
7.7B
-13.0x
---
United StatesRNA
Avidity Biosciences Inc
5.5B
-16.0x
---
United StatesBBIO
BridgeBio Pharma Inc
4.8B
-9.6x
---
As of 2024-10-04

Company Information

Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer. It develops small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases and drive more durable responses. It is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-positive non-small cell lung cancer, and multiple discovery-stage research programs. Its product candidate, NVL-520, is being developed for patients with ROS proto-oncogene 1 (ROS1)-positive non-small cell lung cancer (NSCLC). NVL-520 is a novel ROS1-selective inhibitor. Its product candidate, NVL-655, is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC. LC. NVL-655 is a brain-penetrant ALK-selective inhibitor. Its product candidate, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor.

Contact Information

Headquarters
One Broadway, 14th FloorCAMBRIDGE, MA, United States 02142
Phone
857-357-7000
Fax
302-655-5049

Executives

Non-Executive Independent Chairman of the Board
Anna Protopapas
President, Chief Executive Officer, Director
James Porter
Chief Financial Officer, Treasurer
Alexandra Balcom
Chief Development Officer
Darlene Noci
Chief Medical Officer
Christopher Turner

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$6.8B
Revenue (TTM)
$0.00
Shares Outstanding
65.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.78
Book Value
$10.94
P/E Ratio
-37.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.